Is Oxybenzone safe in cosmetics?
Oxybenzone has a safety rating of "POOR" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Also known as: BRN 1913145, EINECS 205-031-5, NCI-C60957, NSC-7778, Oxibenzonum (+3 more)
INCI: BENZOPHENONE-3
Oxybenzone (CAS 131-57-7) is a cosmetic active ingredient functioning as Broad-spectrum UV filter; absorbs UVB and short-wave UVA radiation (290–320. NOAEL 67.9 mg/kg bw/day (PDF-verified against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 6% (EU Annex VI); SCCS 2021 recommended reduction to 2.2%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 131-57-7 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Oxybenzone.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Oxybenzone. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 544 mg/kg bw/day | oral | mouse | Subchronic | COSMOS_DB |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =0.119 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =1.78 mg/kg bw/day | dermal | rat | dermal absorption | SCCS_vision_codex |
| NOAEL | =67.9 mg/kg bw/d | oral | - | NOAEL study | SCCS_vision_codex |
Pre-calculated NOAEL → SED → MoS audit trail for Oxybenzone across SCCS product categories, with measured dermal absorption where available.
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LD50 | >16000 mg/kg | Rabbit | dermal | acute | ECHA IUCLID |
| LD50 | >12800 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | =11600 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | >1600 mg/kg | Mouse | injection | - | ECHA IUCLID |
| NOAEL | >10000 ppm | Rat | oral | short-term | ECHA IUCLID |
| NOAEL | >789 mg/kg-day | Rat | oral | short-term | ECHA IUCLID |
| NOAEL | =600 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =393 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =429 mg/kg-day | Rat | oral | subchronic | ECHA IUCLID |
| NOAEL | =4925 mg/kg-day | Mouse | oral | subchronic | ECHA IUCLID |
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: CosmEur database; DPRA: Cosmetics Europe; KS: Cosmetics Europe; hCLAT: Cosmetics Europe
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
Source list: II
agonist (ER); antagonist (AR, TR)
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| EC50_ER | ERα | 19.5 µM | agonist |
| IC50_AR | AR | 4.98 µM | antagonist |
| dermal_RF | skin | 0.01 mg/cm² (0.5% of applied dose) mg/cm² | - |
| dermal_RF_16h | skin | 1.0 ± 0.4 µg/cm² | - |
| Cell proliferation | ER | EC50/IC50: ~2 uM (EC50); LOEC: ~0.3 uM; NOEC: 0.1 uM mixed | agonist |
| ERE-driven luciferase induction | ERa | EC50/IC50: EC50 not determinable (partial plateau at 1 uM); LOEC: 1 uM; NOEC: 0.1 uM mixed | weak agonist |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| JP | restricted | Wash-away: No limit | Leave-on: 5.0% | Mucosa: 5.0% | Wash-away: No limit | Leave-on: 5.0% | Mucosa: 5.0% |
| CN | permitted_uv_filter | 10 | All cosmetics |
| IN | permitted_uv_filter | 10.0 | sunscreen and other cosmetic products |
| AU | restricted | - | sunscreens (therapeutic) |
| GCC | restricted | 6.0 | All cosmetics |
| UK | restricted | - | - |
| ID | permitted_uv_filter | 10% (current ASEAN-wide); Vietnam 2026 new limits: 6% facial/hand/lip; 2.2% body; 0.5% other; Indonesia reducing | - |
| ID | restricted | Reducing from 10% (exact new limit TBC; Indonesia aligning with EU) | Sunscreen products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 8.0 | In vitro — Franz diffusion cells | - | SCCS/1223/09 (2013) (2013) |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Sunscreen | 2–6 | 10 | CIR/FDA OTC |
1 property record from structured ingredient metadata.
Expert safety assessment and concern-level summary for Oxybenzone.
Public NOAEL study rows linked to Oxybenzone by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg bw/d, mg/kg/ day
| Absorption % | Method | Vehicle |
|---|---|---|
| 8.0 | In vitro — Franz diffusion cells | Sunscreen o/w / w/o emulsion |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Oxybenzone has a safety rating of "POOR" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Oxybenzone EU regulatory status: restricted. Maximum allowed concentration: 6% (EU Annex VI); SCCS 2021 recommended reduction to 2.2%. This is based on EU Regulation 1223/2009 and its amendments.
Oxybenzone functions as: Broad-spectrum UV filter; absorbs UVB and short-wave UVA radiation (290–320 nm); one of the most widely used chemical UV filters historically in the US market. It is classified as a Active Ingredient in our database. CAS number: 131-57-7.
The NOAEL (No Observed Adverse Effect Level) for Oxybenzone is 544 mg/kg bw/day based on a Subchronic study via oral route in mouse. A total of 10 study endpoints are available. Source: COSMOS_DB.
Oxybenzone also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Oxybenzone compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Oxybenzone in your formulation.